Signal2026-06-09
ClinicalTrials.gov

[PHASE1] Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer

Part of

Molecular Profiling In Endocrine Neoplasms